Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 10/20 | 0.55 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.49 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.49 |
| ▸ | RARB | P10826 | 1/20 | 0.49 |
| ▸ | RARG | P13631 | 1/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ornoprostil SCHEMBL960131 | 1.00 | PTGIR (0.55) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| Ornoprostil SCHEMBL960133 | 1.00 | PTGIR (0.55) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11453626 | 0.97 | PTGIR (0.53) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11379011 | 0.95 | PTGIR (0.49) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL10353215 | 0.91 | PTGIR (0.51) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL10353216 | 0.91 | PTGIR (0.51) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL10353089 | 0.91 | PTGIR (0.51) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL10879707 | 0.91 | PTGIR (0.58) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL958202 | 0.90 | PTGIR (0.68) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL958197 | 0.90 | PTGIR (0.68) | PTGIRPTGER2PTGER4TSHRABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4732210-A1 | ENVIRONMENTAL ATTRIBUTES FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND/OR INTERMEDIATES THEREOF | BASF SE (DE) | 2026-04-29 | — | — | EP | claimed |
| US-12569437-B2 | Disease-site-specific liposomal formulation | OSAKA UNIVERSITY (JP) | 2026-03-10 | — | — | US | claimed |
| EP-3895686-B1 | NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT | FRAUNHOFER GES FORSCHUNG (DE) | 2025-04-09 | — | — | EP | claimed |
| WO-2024260988-A1 | ENVIRONMENTAL ATTRIBUTES FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND/OR INTERMEDIATES THEREOF | BASF SE (DE) | 2024-12-26 | — | — | WO | claimed |
| CN-119135238-A | GCN-based low-rail internet routing mechanism SDC vulnerability prediction method | 南京航空航天大学 | 2024-12-13 | — | — | CN | claimed |
| CN-119089509-A | Program branch data integrity protection method, system, equipment and medium based on compiler | 西安电子科技大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118227138-A | Computing compiling optimization realization method and system based on error-free transformation | 中国人民解放军国防科技大学 | 2024-06-21 | — | — | CN | claimed |
| US-20240082154-A1 | DISEASE-SITE-SPECIFIC LIPOSOMAL FORMULATION | CUORIPS INC. (JP) | 2024-03-14 | — | — | US | claimed |
| CN-115794120-B | Dynamic program dependency cluster detection method based on higher-order function | 南京邮电大学 | 2023-07-04 | — | — | CN | claimed |
| CN-116305158-A | Vulnerability identification method based on slice code dependency graph semantic learning | 天翼云科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| WO-1994009440-A1 | METHOD AND APPARATUS FOR FILTERING POINT-OF-SALE DATA | CATALINA MARKETING INTERNATIONAL, INC. (US) | 1994-04-28 | — | — | WO | claimed |
| EP-0583482-A1 | REMEDY FOR WOUND OR HEMORRHOID | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1994-02-23 | — | — | EP | claimed |
| EP-0513137-A1 | ARRANGEMENT FOR A DISTRIBUTED CONTROL SYSTEM. | LENNARTSSON KENT (SE) | 1992-11-19 | — | — | EP | claimed |
| EP-0474812-A1 | DYNAMIC ALLOCATION OF ROAMER ROUTING NUMBERS SYSTEM AND METHOD. | ERICSSON TELEFON AB L M (SE) | 1992-03-18 | — | — | EP | claimed |
| WO-1991014349-A1 | DYNAMIC ALLOCATION OF ROAMER ROUTING NUMBERS SYSTEM AND METHOD | TELEFONAKTIEBOLAGET LM ERICSSON (SE) | 1991-09-19 | — | — | WO | claimed |
| WO-1991010960-A1 | ARRANGEMENT FOR A DISTRIBUTED CONTROL SYSTEM | LENNARTSSON KENT (SE) | 1991-07-25 | — | — | WO | claimed |
| EP-0364638-A1 | Communication network | International Business Machines Corporation (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0346141-A2 | High performance memory imaging network for a real time process control system | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1989-12-13 | — | — | EP | claimed |
| EP-0232807-A1 | Apparatus and method for controlling chemical and physical processes in a plurality of devices suitable for this purpose | Degussa Aktiengesellschaft (DE) | 1987-08-19 | — | — | EP | claimed |
| US-4278688-A | Prostaglandin analogues | ONO PHARMACEUTICAL CO. (JP) | 1981-07-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569437-B2 | Disease-site-specific liposomal formulation | PTGER1, PLA2R1, LPAR2 | PTGIR 17/4885PTGER2 7/4885PTGER4 19/4885 |
| US-20240082154-A1 | DISEASE-SITE-SPECIFIC LIPOSOMAL FORMULATION | LPAR2, PLA2R1, PTGDR2 | PTGIR 10/4885PTGER2 12/4885PTGER4 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.